A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity

K Das, E Belnoue, M Rossi, T Hofer… - Nature …, 2021 - nature.com
Functional tumor-specific cytotoxic T cells elicited by therapeutic cancer vaccination in
combination with oncolytic viruses offer opportunities to address resistance to checkpoint …

A VSV-based assay quantifies coronavirus Mpro/3CLpro/Nsp5 main protease activity and chemical inhibition

E Heilmann, F Costacurta, S Geley… - Communications …, 2022 - nature.com
Protease inhibitors are among the most powerful antiviral drugs. However, for SARS-CoV-2
only a small number of protease inhibitors have been identified thus far and there is still a …

Mcl-1 Protein and Viral Infections: A Narrative Review

Z Wyżewski, J Stępkowska, AM Kobylińska… - International Journal of …, 2024 - mdpi.com
MCL-1 is the prosurvival member of the Bcl-2 family. It prevents the induction of
mitochondria-dependent apoptosis. The molecular mechanisms dictating the host cell …

A universal fluorescence polarization high throughput screening assay to target the SAM-binding sites of SARS-CoV-2 and other viral methyltransferases

SK Samrat, Q Bashir, R Zhang, Y Huang… - Emerging Microbes & …, 2023 - Taylor & Francis
ABSTRACT SARS-CoV-2 has caused a global pandemic with significant humanity and
economic loss since 2020. Currently, only limited options are available to treat SARS-CoV-2 …

Study of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir

L Krismer, H Schöppe, S Rauch, D Bante, B Sprenger… - npj Viruses, 2024 - nature.com
Abstract The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is an epidemic,
zoonotically emerging pathogen initially reported in Saudi Arabia in 2012. MERS-CoV has …

Vesicular stomatitis virus as a platform for protease activity measurements

S Rauch, F Costacurta, D von Laer… - Current …, 2024 - Wiley Online Library
Protease inhibitors are among the most powerful antiviral drugs. They have been used
successfully against viruses, such as the human immunodeficiency virus (HIV), hepatitis C …

Antiviral activity of intracellular nanobodies targeting the influenza virus RNA-polymerase core

M Bessonne, J Morel, Q Nevers, B Da Costa… - PLoS …, 2024 - journals.plos.org
Influenza viruses transcribe and replicate their genome in the nucleus of the infected cells,
two functions that are supported by the viral RNA-dependent RNA-polymerase (FluPol) …

An HPLC-SEC-based rapid quantification method for vesicular stomatitis virus particles to facilitate process development

A Schimek, JKM Ng, I Basbas, F Martin, D Xin… - … Therapy Methods & …, 2024 - cell.com
Virus particle (VP) quantification plays a pivotal role in the development of production
processes of VPs for virus-based therapies. The yield based on total VP count serves as a …

Nanopore assay reveals cell-type-dependent gene expression of vesicular stomatitis indiana virus and differential host cell response

B Kakuk, AA Kiss, G Torma, Z Csabai, I Prazsák… - Pathogens, 2021 - mdpi.com
Vesicular stomatitis Indiana virus (VSIV) of genus Vesiculovirus, species Indiana
Vesiculovirus (formerly as Vesicular stomatitis virus, VSV) causes a disease in livestock that …

The Multiplicity of Infection of Recombinant Vaccinia Virus Expressing the T7 RNA Polymerase Determines the Rescue Efficiency of Vesicular Stomatitis Virus

F Yang, J Tan, Y Fang, G Chen, Y Zhang… - Frontiers in …, 2022 - frontiersin.org
Vesicular stomatitis virus (VSV) has a wide range of cell tropism, making it a prototype of
studying the negative-strand RNA virus (NSRV), including virus–host interactions and …